1. Home
  2. HLX vs CDNA Comparison

HLX vs CDNA Comparison

Compare HLX & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helix Energy Solutions Group Inc.

HLX

Helix Energy Solutions Group Inc.

HOLD

Current Price

$9.91

Market Cap

1.4B

Sector

Energy

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$37.14

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLX
CDNA
Founded
1979
1998
Country
United States
United States
Employees
2212
N/A
Industry
Oilfield Services/Equipment
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
1996
2007

Fundamental Metrics

Financial Performance
Metric
HLX
CDNA
Price
$9.91
$37.14
Analyst Decision
Strong Buy
Buy
Analyst Count
2
6
Target Price
$11.50
$28.00
AVG Volume (30 Days)
1.4M
1.1M
Earning Date
04-22-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
$876,561,000.00
$48,324,000.00
Revenue This Year
$2.05
$16.01
Revenue Next Year
$5.46
$11.31
P/E Ratio
N/A
$752.20
Revenue Growth
3.60
18.93
52 Week Low
$5.58
$11.26
52 Week High
$10.75
$40.47

Technical Indicators

Market Signals
Indicator
HLX
CDNA
Relative Strength Index (RSI) 63.16 72.16
Support Level $9.21 $15.89
Resistance Level $9.89 $40.47
Average True Range (ATR) 0.27 1.70
MACD 0.09 0.51
Stochastic Oscillator 91.61 77.26

Price Performance

Historical Comparison
HLX
CDNA

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. The Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S., and it also has its presence in North Sea, Brazil, Asia Pacific, West Africa, and Other.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: